Skip to main content
FinSpry Logo
FinSpry
NPCE logo
NPCE
(NASDAQ)
NeuroPace, Inc.
$14.65-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

NeuroPace (NPCE) Stock Price & Financial Analysis

NeuroPace Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$13.42 - $14.65
52-Week High$18.98
52-Week Low$7.56
Open$13.71
Volume170.41K
Average Volume (3M)170.41K
Market Cap479.38M
Shares Outstanding32.72M
Price to Sales (P/S)4.60
Price to Book (P/B)24.19
EV/EBITDA-40.13
Revenue (TTM)99.99M
Net Income (TTM)-21.46M
Free Cash Flow (TTM)-11.34M
EPS (TTM)$-0.66
Profit Margin-21.47%
Operating Margin-16.34%
Return on Equity (ROE)-112.79%
Debt to Equity3.72
50-Day MA$14.61
200-Day MA$12.48
52-Week Change7.32%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About NeuroPace

What is the current stock price for NPCE?

As of the latest trading session, NPCE stock trades at $14.65. The 52-week range is $7.56–$18.98, with a day range of $13.41–$14.65.

What is the P/E ratio for NPCE?

The P/E ratio (Price-to-Earnings) for NPCE is shown in the Key Statistics section. This valuation metric helps compare NeuroPace, Inc. to industry peers.

Does NPCE pay dividends?

NeuroPace does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for NPCE?

Based on 1 analyst, the consensus for NPCE is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of NPCE?

NeuroPace's market capitalization is $479.4M, classifying it as a small-cap company. NeuroPace operates in the Healthcare sector within the Medical Devices industry.